APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepcidin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hepcidin Industry Growth and Trends Forecast to 2032

22 December 202571 pages

Choose your research edition.

Industry ResearchHepcidin Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepcidin Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Hepcidin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepcidin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepcidin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Hepcidin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepcidin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hepcidin include Protagonist Therapeutics Inc, Pieris Pharmaceuticals Inc, Noxxon Pharma AG and Daiichi Sankyo Co Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hepcidin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hepcidin market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hepcidin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hepcidin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hepcidin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hepcidin Market by Company

Protagonist Therapeutics Inc

Pieris Pharmaceuticals Inc

Noxxon Pharma AG

Daiichi Sankyo Co Ltd

Hepcidin Segment by Type

PTG-300

PRS-080

M-009

DS-79182026

Others

Hepcidin Segment by Application

Acute Inflammation

Sickle Cell Disease

Anemia

Iron Deficiency Anemia

Others

Hepcidin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepcidin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepcidin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepcidin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepcidin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hepcidin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of PTG-300 Table 2. Major Company of PRS-080 Table 3. Major Company of M-009 Table 4. Major Company of DS-79182026 Table 5. Major Company of Others Table 6. Global Hepcidin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Hepcidin Sales by Type (2021-2026) & (k units) Table 8. Global Hepcidin Sales Market Share in Volume by Type (2021-2026) Table 9. Global Hepcidin Sales by Type (2021-2026) & (US$ Million) Table 10. Global Hepcidin Sales Market Share in Value by Type (2021-2026) Table 11. Global Hepcidin Price by Type (2021-2026) & (US$/unit) Table 12. Global Hepcidin Sales by Type (2027-2032) & (k units) Table 13. Global Hepcidin Sales Market Share in Volume by Type (2027-2032) Table 14. Global Hepcidin Sales by Type (2027-2032) & (US$ Million) Table 15. Global Hepcidin Sales Market Share in Value by Type (2027-2032) Table 16. Global Hepcidin Price by Type (2027-2032) & (US$/unit) Table 17. North America Hepcidin Sales by Type (2021-2026) & (k units) Table 18. North America Hepcidin Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Hepcidin Sales by Type (2021-2026) & (k units) Table 20. Europe Hepcidin Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Hepcidin Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Hepcidin Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Hepcidin Sales by Type (2021-2026) & (k units) Table 24. Latin America Hepcidin Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Hepcidin Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Hepcidin Sales by Type (2021-2026) & (US$ Million) Table 27. Hepcidin Industry Trends Table 28. Hepcidin Industry Drivers Table 29. Hepcidin Industry Opportunities and Challenges Table 30. Hepcidin Industry Restraints Table 31. Global Hepcidin Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Hepcidin Revenue Market Share by Company (2021-2026) Table 33. Global Hepcidin Sales by Company (2021-2026) & (k units) Table 34. Global Hepcidin Sales Share by Company (2021-2026) Table 35. Global Hepcidin Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Hepcidin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Hepcidin Major Company Production Sites and Headquarters Table 38. Global Hepcidin Company, Product Type & Application Table 39. Global Hepcidin Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Hepcidin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Hepcidin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Hepcidin Sales by Region (2021-2026) & (k units) Table 44. Global Hepcidin Sales Market Share in Volume by Region (2021-2026) Table 45. Global Hepcidin Sales by Region (2021-2026) & (US$ Million) Table 46. Global Hepcidin Sales Market Share in Value by Region (2021-2026) Table 47. Global Hepcidin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Hepcidin Sales by Region (2027-2032) & (k units) Table 49. Global Hepcidin Sales Market Share in Volume by Region (2027-2032) Table 50. Global Hepcidin Sales by Region (2027-2032) & (US$ Million) Table 51. Global Hepcidin Sales Market Share in Value by Region (2027-2032) Table 52. Global Hepcidin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Hepcidin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Hepcidin Sales by Application (2021-2026) & (k units) Table 55. Global Hepcidin Sales Market Share in Volume by Application (2021-2026) Table 56. Global Hepcidin Sales by Application (2021-2026) & (US$ Million) Table 57. Global Hepcidin Sales Market Share in Value by Application (2021-2026) Table 58. Global Hepcidin Price by Application (2021-2026) & (US$/unit) Table 59. Global Hepcidin Sales by Application (2027-2032) & (k units) Table 60. Global Hepcidin Sales Market Share in Volume by Application (2027-2032) Table 61. Global Hepcidin Sales by Application (2027-2032) & (US$ Million) Table 62. Global Hepcidin Sales Market Share in Value by Application (2027-2032) Table 63. Global Hepcidin Price by Application (2027-2032) & (US$/unit) Table 64. North America Hepcidin Sales by Application (2021-2026) & (k units) Table 65. North America Hepcidin Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Hepcidin Sales by Application (2021-2026) & (k units) Table 67. Europe Hepcidin Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Hepcidin Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Hepcidin Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Hepcidin Sales by Application (2021-2026) & (k units) Table 71. Latin America Hepcidin Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Hepcidin Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Hepcidin Sales by Application (2021-2026) & (US$ Million) Table 74. Protagonist Therapeutics Inc Company Information Table 75. Protagonist Therapeutics Inc Business Overview Table 76. Protagonist Therapeutics Inc Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Protagonist Therapeutics Inc Hepcidin Product Portfolio Table 78. Protagonist Therapeutics Inc Recent Development Table 79. Pieris Pharmaceuticals Inc Company Information Table 80. Pieris Pharmaceuticals Inc Business Overview Table 81. Pieris Pharmaceuticals Inc Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Pieris Pharmaceuticals Inc Hepcidin Product Portfolio Table 83. Pieris Pharmaceuticals Inc Recent Development Table 84. Noxxon Pharma AG Company Information Table 85. Noxxon Pharma AG Business Overview Table 86. Noxxon Pharma AG Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Noxxon Pharma AG Hepcidin Product Portfolio Table 88. Noxxon Pharma AG Recent Development Table 89. Daiichi Sankyo Co Ltd Company Information Table 90. Daiichi Sankyo Co Ltd Business Overview Table 91. Daiichi Sankyo Co Ltd Hepcidin Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Daiichi Sankyo Co Ltd Hepcidin Product Portfolio Table 93. Daiichi Sankyo Co Ltd Recent Development Table 94. North America Hepcidin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 95. North America Hepcidin Sales by Country (2021-2026) & (k units) Table 96. North America Hepcidin Sales Market Share by Country (2021-2026) Table 97. North America Hepcidin Sales Forecast by Country (2027-2032) & (k units) Table 98. North America Hepcidin Sales Market Share Forecast by Country (2027-2032) Table 99. North America Hepcidin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 100. North America Hepcidin Market Size by Country (2021-2026) & (US$ Million) Table 101. North America Hepcidin Market Share by Country (2021-2026) Table 102. North America Hepcidin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 103. North America Hepcidin Market Share Forecast by Country (2027-2032) Table 104. Europe Hepcidin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 105. Europe Hepcidin Sales by Country (2021-2026) & (k units) Table 106. Europe Hepcidin Sales Market Share by Country (2021-2026) Table 107. Europe Hepcidin Sales Forecast by Country (2027-2032) & (k units) Table 108. Europe Hepcidin Sales Market Share Forecast by Country (2027-2032) Table 109. Europe Hepcidin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 110. Europe Hepcidin Market Size by Country (2021-2026) & (US$ Million) Table 111. Europe Hepcidin Market Share by Country (2021-2026) Table 112. Europe Hepcidin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 113. Europe Hepcidin Market Share Forecast by Country (2027-2032) Table 114. Asia-Pacific Hepcidin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 115. Asia-Pacific Hepcidin Sales by Country (2021-2026) & (k units) Table 116. Asia-Pacific Hepcidin Sales Market Share by Country (2021-2026) Table 117. Asia-Pacific Hepcidin Sales Forecast by Country (2027-2032) & (k units) Table 118. Asia-Pacific Hepcidin Sales Market Share Forecast by Country (2027-2032) Table 119. Asia-Pacific Hepcidin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 120. Asia-Pacific Hepcidin Market Size by Country (2021-2026) & (US$ Million) Table 121. Asia-Pacific Hepcidin Market Share by Country (2021-2026) Table 122. Asia-Pacific Hepcidin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 123. Asia-Pacific Hepcidin Market Share Forecast by Country (2027-2032) Table 124. Latin America Hepcidin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 125. Latin America Hepcidin Sales by Country (2021-2026) & (k units) Table 126. Latin America Hepcidin Sales Market Share by Country (2021-2026) Table 127. Latin America Hepcidin Sales Forecast by Country (2027-2032) & (k units) Table 128. Latin America Hepcidin Sales Market Share Forecast by Country (2027-2032) Table 129. Latin America Hepcidin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 130. Latin America Hepcidin Market Size by Country (2021-2026) & (US$ Million) Table 131. Latin America Hepcidin Market Share by Country (2021-2026) Table 132. Latin America Hepcidin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 133. Latin America Hepcidin Market Share Forecast by Country (2027-2032) Table 134. Middle East and Africa Hepcidin Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. Middle East and Africa Hepcidin Sales by Country (2021-2026) & (k units) Table 136. Middle East and Africa Hepcidin Sales Market Share by Country (2021-2026) Table 137. Middle East and Africa Hepcidin Sales Forecast by Country (2027-2032) & (k units) Table 138. Middle East and Africa Hepcidin Sales Market Share Forecast by Country (2027-2032) Table 139. Middle East and Africa Hepcidin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. Middle East and Africa Hepcidin Market Size by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Hepcidin Market Share by Country (2021-2026) Table 142. Middle East and Africa Hepcidin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. Middle East and Africa Hepcidin Market Share Forecast by Country (2027-2032) Table 144. Key Raw Materials Table 145. Raw Materials Key Suppliers Table 146. Hepcidin Distributors List Table 147. Hepcidin Customers List Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources Table 151. Primary Sources List of Figures Figure 1. Hepcidin Image Figure 2. Global Hepcidin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepcidin Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepcidin Sales (2021-2032) & (k units) Figure 5. PTG-300 Image Figure 6. Global PTG-300 Sales YoY Growth (2021-2032) & (k units) Figure 7. PRS-080 Image Figure 8. Global PRS-080 Sales YoY Growth (2021-2032) & (k units) Figure 9. M-009 Image Figure 10. Global M-009 Sales YoY Growth (2021-2032) & (k units) Figure 11. DS-79182026 Image Figure 12. Global DS-79182026 Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Hepcidin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Hepcidin Market Share by Type 2025 VS 2032 Figure 17. North America Hepcidin Sales Market Share in Volume by Type in 2025 Figure 18. North America Hepcidin Sales Market Share in Value by Type in 2025 Figure 19. Europe Hepcidin Sales Market Share in Volume by Type in 2025 Figure 20. Europe Hepcidin Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Hepcidin Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Hepcidin Sales Market Share in Value by Type in 2025 Figure 23. Latin America Hepcidin Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Hepcidin Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Hepcidin Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Hepcidin Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Hepcidin Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Acute Inflammation Image Figure 30. Global Acute Inflammation Sales YoY Growth (2021-2032) & (k units) Figure 31. Sickle Cell Disease Image Figure 32. Global Sickle Cell Disease Sales YoY Growth (2021-2032) & (k units) Figure 33. Anemia Image Figure 34. Global Anemia Sales YoY Growth (2021-2032) & (k units) Figure 35. Iron Deficiency Anemia Image Figure 36. Global Iron Deficiency Anemia Sales YoY Growth (2021-2032) & (k units) Figure 37. Others Image Figure 38. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 39. Global Hepcidin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Hepcidin Market Share by Application 2025 VS 2032 Figure 41. North America Hepcidin Sales Market Share in Volume by Application in 2025 Figure 42. North America Hepcidin Sales Market Share in Value by Application in 2025 Figure 43. Europe Hepcidin Sales Market Share in Volume by Application in 2025 Figure 44. Europe Hepcidin Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific Hepcidin Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific Hepcidin Sales Market Share in Value by Application in 2025 Figure 47. Latin America Hepcidin Sales Market Share in Volume by Application in 2025 Figure 48. Latin America Hepcidin Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa Hepcidin Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa Hepcidin Sales Market Share in Value by Application in 2025 Figure 51. North America Hepcidin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. North America Hepcidin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America Hepcidin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America Hepcidin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Hepcidin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Europe Hepcidin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Hepcidin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe Hepcidin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Hepcidin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Asia-Pacific Hepcidin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Hepcidin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific Hepcidin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Hepcidin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 64. Latin America Hepcidin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Hepcidin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America Hepcidin Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Hepcidin Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 68. Middle East and Africa Hepcidin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Hepcidin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa Hepcidin Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. Hepcidin Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. Hepcidin Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • PTG-300
  • PRS-080
  • M-009
  • DS-79182026
  • Others
Applications
  • Acute Inflammation
  • Sickle Cell Disease
  • Anemia
  • Iron Deficiency Anemia
  • Others
Companies covered
  • Protagonist Therapeutics Inc
  • Pieris Pharmaceuticals Inc
  • Noxxon Pharma AG
  • Daiichi Sankyo Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hepcidin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hepcidin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hepcidin Market by Type
  6. 1.3.1 PTG-300
  7. 1.3.2 PRS-080
  8. 1.3.3 M-009
  9. 1.3.4 DS-79182026
  10. 1.3.5 Others
  11. 1.4 Global Hepcidin Market Size by Type
  12. 1.4.1 Global Hepcidin Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Hepcidin Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Hepcidin Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Hepcidin Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Hepcidin Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Hepcidin Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Hepcidin Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Hepcidin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hepcidin Industry Trends
  2. 2.2 Hepcidin Industry Drivers
  3. 2.3 Hepcidin Industry Opportunities and Challenges
  4. 2.4 Hepcidin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hepcidin Revenue (2021-2026)
  2. 3.2 Global Top Players by Hepcidin Sales (2021-2026)
  3. 3.3 Global Top Players by Hepcidin Price (2021-2026)
  4. 3.4 Global Hepcidin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepcidin Major Company Production Sites & Headquarters
  6. 3.6 Global Hepcidin Company, Product Type & Application
  7. 3.7 Global Hepcidin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepcidin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepcidin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepcidin Tier 1, Tier 2, and Tier 3
4 Hepcidin Regional Status and Outlook
  1. 4.1 Global Hepcidin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hepcidin Historic Market Size by Region
  3. 4.2.1 Global Hepcidin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hepcidin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hepcidin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hepcidin Forecasted Market Size by Region
  7. 4.3.1 Global Hepcidin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hepcidin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hepcidin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hepcidin by Application
  1. 5.1 Hepcidin Market by Application
  2. 5.1.1 Acute Inflammation
  3. 5.1.2 Sickle Cell Disease
  4. 5.1.3 Anemia
  5. 5.1.4 Iron Deficiency Anemia
  6. 5.1.5 Others
  7. 5.2 Global Hepcidin Market Size by Application
  8. 5.2.1 Global Hepcidin Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Hepcidin Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Hepcidin Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Hepcidin Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Hepcidin Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Hepcidin Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Hepcidin Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Hepcidin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Protagonist Therapeutics Inc
  2. 6.1.1 Protagonist Therapeutics Inc Company Information
  3. 6.1.2 Protagonist Therapeutics Inc Business Overview
  4. 6.1.3 Protagonist Therapeutics Inc Hepcidin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Protagonist Therapeutics Inc Hepcidin Product Portfolio
  6. 6.1.5 Protagonist Therapeutics Inc Recent Developments
  7. 6.2 Pieris Pharmaceuticals Inc
  8. 6.2.1 Pieris Pharmaceuticals Inc Company Information
  9. 6.2.2 Pieris Pharmaceuticals Inc Business Overview
  10. 6.2.3 Pieris Pharmaceuticals Inc Hepcidin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pieris Pharmaceuticals Inc Hepcidin Product Portfolio
  12. 6.2.5 Pieris Pharmaceuticals Inc Recent Developments
  13. 6.3 Noxxon Pharma AG
  14. 6.3.1 Noxxon Pharma AG Company Information
  15. 6.3.2 Noxxon Pharma AG Business Overview
  16. 6.3.3 Noxxon Pharma AG Hepcidin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Noxxon Pharma AG Hepcidin Product Portfolio
  18. 6.3.5 Noxxon Pharma AG Recent Developments
  19. 6.4 Daiichi Sankyo Co Ltd
  20. 6.4.1 Daiichi Sankyo Co Ltd Company Information
  21. 6.4.2 Daiichi Sankyo Co Ltd Business Overview
  22. 6.4.3 Daiichi Sankyo Co Ltd Hepcidin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Daiichi Sankyo Co Ltd Hepcidin Product Portfolio
  24. 6.4.5 Daiichi Sankyo Co Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Hepcidin Sales by Country
  2. 7.1.1 North America Hepcidin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hepcidin Sales by Country (2021-2026)
  4. 7.1.3 North America Hepcidin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hepcidin Market Size by Country
  6. 7.2.1 North America Hepcidin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hepcidin Market Size by Country (2021-2026)
  8. 7.2.3 North America Hepcidin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hepcidin Sales by Country
  2. 8.1.1 Europe Hepcidin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hepcidin Sales by Country (2021-2026)
  4. 8.1.3 Europe Hepcidin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hepcidin Market Size by Country
  6. 8.2.1 Europe Hepcidin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hepcidin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hepcidin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hepcidin Sales by Country
  2. 9.1.1 Asia-Pacific Hepcidin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hepcidin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hepcidin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hepcidin Market Size by Country
  6. 9.2.1 Asia-Pacific Hepcidin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hepcidin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hepcidin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hepcidin Sales by Country
  2. 10.1.1 South America Hepcidin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hepcidin Sales by Country (2021-2026)
  4. 10.1.3 South America Hepcidin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hepcidin Market Size by Country
  6. 10.2.1 South America Hepcidin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hepcidin Market Size by Country (2021-2026)
  8. 10.2.3 South America Hepcidin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hepcidin Sales by Country
  2. 11.1.1 Middle East and Africa Hepcidin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hepcidin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hepcidin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hepcidin Market Size by Country
  6. 11.2.1 Middle East and Africa Hepcidin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hepcidin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hepcidin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hepcidin Value Chain Analysis
  2. 12.1.1 Hepcidin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hepcidin Production Mode & Process
  7. 12.2 Hepcidin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hepcidin Distributors
  10. 12.2.3 Hepcidin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst